SCHEMBL24767906

SCHEMBL24767906

c1cnc2c(c1)[nH]c1c2c2cccnc2c2sc3ccccc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.49
GABRG2 P18507 3/20 0.49
GABRB3 P28472 3/20 0.49
GABRA5 P31644 3/20 0.49
GABRA3 P34903 3/20 0.49
GABRA2 P47869 3/20 0.49
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
MAP3K9 P80192 3/20 0.46
MAP3K11 Q16584 3/20 0.46
CDK4 P11802 3/20 0.46
CCND1 P24385 3/20 0.46
NTRK1 P04629 1/20 0.44
MAP3K10 Q02779 1/20 0.44
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
PARP1 P09874 3/20 0.42
KRAS P01116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24768257 0.92 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988475 0.90 MEN1 (0.53) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988482 0.89 MEN1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988607 0.84 MAP3K9 (0.55) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988477 0.83 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23353333 0.80 TNKS (0.67) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL13556881 0.79 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL16751658 0.79 GABRA1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL15318798 0.78 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL15318814 0.77 CDK4 (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, SLCO2A1, SLCO2B1 GABRA1 2684/4885GABRG2 3489/4885GABRB3 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.